PharmacoPlatform: Passerelles ICSR ICH E2B(R3), Calcul de Disproportion et Détection de Signaux
PharmacoPlatform fournit des architectures logicielles de pharmacovigilance d'entreprise, automatisant l'ingestion des déclarations d'effets indésirables (ICSR), l'extraction par TAL d'événements indésirables et la détection de signaux selon FDA FAERS et EMA EudraVigilance.
PharmacoPlatform Global Pharmacovigilance & Signal Detection Pipeline
Multichannel safety intake, MedDRA NLP normalization, and disproportionality scoring
Central System: Pharmacovigilance Core - E2B(R3) Engine & Disproportionality Analyzer
Clinical IoMT Nodes
- Multichannel Safety Intake Sink
- Clinical NLP / MedDRA Auto-Coder
- Individual Case Safety Report (ICSR) Core
- Disproportionality Signal Engine
- Regulatory Gateway Dispatcher
Architectural Layers & Regulatory Standards
- Multisource Adverse Event Ingestion (Optical Character Recognition (OCR) / Multi-Tenant Intake APIs): Ingesting adverse event reports from clinical trials, spontaneous patient hotlines, scientific literature, and social platforms.
- Medical Ontology Normalization (Clinical Transformer Models / MedDRA Dictionary v26+): Mapping unstructured patient symptom descriptions into standardized Medical Dictionary for Regulatory Activities (MedDRA) terms.
- Statistical Signal Detection & Disproportionality (Bayesian Confidence Propagation Neural Network (BCPNN)): Computing Proportional Reporting Ratios (PRR) and empirical Bayes geometric means to detect emerging safety signals.
- Automated Regulatory Electronic Submission (AS2 Secure Gateway / E2B(R3) XML Validator): Validating and transmitting expedited 7-day and 15-day safety reports to FDA FAERS and EudraVigilance.
Key Metrics: < 15 min (Automated ICSR Processing Time) | 99.4% (MedDRA Coding Accuracy) | 100% (ICH E2B(R3) XML Schema Compliance) | Real-Time (Adverse Signal Disproportionality Mining)
Pharmacovigilance automatisée, rapports de sécurité E2B(R3) et détection de signaux d'effets indésirables des médicaments (EIM)
Authoritative technical engineering reference for automated pharmacovigilance, e2b(r3) safety reporting & adverse drug reaction (adr) signal detection in FDA Premarket submissions, EU MDR, IEC 62304 Class C software lifecycle, ISO 13485 quality systems, and IoMT zero-trust interoperability.
Core Engineering Areas
Technical Articles
Related Cluster Architecture Specifications
- HealthVigilance — Zero-Trust IoMT Architecture, SaMD Risk Engineering & Autonomous Clinical Post-Market Vigilance
- AgenticSaMD — Autonomous Agentic Software as a Medical Device, Multi-Agent Clinical Decision Support & FDA GMLP Guardrails
- AITelemonitoring — Autonomous AI Telemonitoring, Virtual Nursing Assistants & Predictive Clinical Deterioration Scoring
- BCI2IoMT — Brain-Computer Interface IoMT Gateways, Neural Decoding & Electrophysiological Streaming